Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers

References

• Berezin AE Kremzer AA Samura TA Berezina TA Kruzliak P Immune phenotypes of endothelial-derived microparticles in dysmetabolic patients J Proteomics Bioinform 2015 8 3 60
   Google Scholar
• Eckel RH Grundy SM Zimmet PZ The metabolic syndrome Lancet 2005 365 9468 1415 1428 15836891
   PubMed Web of Science ®Google Scholar
• Wilson PWF D’Agostino RB Parise H Sullivan L Meigs JB Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus Circulation 2005 112 20 3066 3072 16275870
   PubMed Web of Science ®Google Scholar
• Burger D Schock S Thompson CS Montezano AC Hakim AM Touyz RM Microparticles: biomarkers and beyond Clin Sci 2013 124 7 423 441 23249271
   PubMed Web of Science ®Google Scholar
• Xu MD Wu XZ Zhou Y Xue Y Zhang KQ Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes Am J Transl Res 2016 8 1 209 27069554
   PubMed Web of Science ®Google Scholar
• Zaghloul A Al-Bukhari TAMA Al-Pakistani HA Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: their role in the prediction of vascular complications Diabetes Res Clin Pract 2014 106 3 597 604 25312870
   PubMed Web of Science ®Google Scholar
• Ahmadi A Leipsic J Feuchtner G Is metabolic syndrome predictive of prevalence, extent, and risk of coronary artery disease beyond its components? Results from the multinational coronary CT angiography evaluation for clinical outcome: an international multicenter registry (confirm) PLoS One 2015 10 3 e0118998 25734639
   PubMed Web of Science ®Google Scholar
• Barteneva NS Fasler-Kan E Bernimoulin M Circulating microparticles: square the circle BMC Cell Biol 2013 14 1 23 23607880
   PubMed Web of Science ®Google Scholar
• Ardoin SP Shanahan JC Pisetsky DS The role of microparticles in inflammation and thrombosis Scand J Immunol 2007 66 2–3 159 165 17635793
   PubMed Web of Science ®Google Scholar
• Milioli M Ibáñez-Vea M Sidoli S Palmisano G Careri M Larsen MR Quantitative proteomics analysis of platelet-derived microparticles reveals distinct protein signatures when stimulated by different physiological agonists J Proteomics 2015 121 56 66 25835965
   PubMed Web of Science ®Google Scholar
• Roberts CK Sindhu KK Oxidative stress and metabolic syndrome Life Sci 2009 84 21–22 705 712 19281826
   PubMed Web of Science ®Google Scholar
• Bellanti F Matteo M Rollo T Sex hormones modulate circulating antioxidant enzymes: impact of estrogen therapy Redox Biol 2013 1 1 340 346 24024169
   PubMed Web of Science ®Google Scholar
• Samsam-Shariat SZ Bolhasani M Sarrafzadegan N Najafi S Asgary S Relationship between blood peroxidases activity and visfatin levels in metabolic syndrome patients ARYA Atheroscler 2014 10 4 218 226 25258638
   PubMedGoogle Scholar
• Dellas C Loskutoff DJ Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease Thromb Haemost 2005 93 4 631 640 15841306
   PubMed Web of Science ®Google Scholar
• Kohler HP Grant PJ Plasminogen-activator inhibitor type 1 and coronary artery disease N Engl J Med 2000 342 24 1792 1801 10853003
   PubMed Web of Science ®Google Scholar
• Lijnen HR Pleiotropic functions of plasminogen activator inhibitor-1 J Thromb Haemost 2005 3 1 35 45 15634264
   PubMed Web of Science ®Google Scholar
• Anand SS Yi Q Gerstein H Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease Circulation 2003 108 4 420 425 12860914
   PubMed Web of Science ®Google Scholar
• Berezin AE Kremzer AA Martovitskaya YV Samura TA Berezina TA The predictive role of circulating microparticles in patients with chronic heart failure BBA Clin 2015 3 18 24 26672475
   PubMedGoogle Scholar
• Thomas GN Ho SY Janus ED The US national cholesterol education programme adult treatment panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population Diabetes Res Clin Pract 2005 67 3 251 257 15713358
   PubMed Web of Science ®Google Scholar
• Gierach M Gierach J Ewertowska M Arndt A Junik R Correlation between body mass index and waist circumference in patients with metabolic syndrome ISRN Endocrinol 2014 2014 10 1 6
   Google Scholar
• Hekmatdoost A Mirmiran P Hosseini-Esfahani F Azizi F Dietary fatty acid composition and metabolic syndrome in Tehranian adults Nutrition 2011 27 10 1002 1007 21907897
   PubMed Web of Science ®Google Scholar
• Nasreddine L Ouaijan K Mansour M Adra N Sinno D Hwalla N Metabolic syndrome and insulin resistance in obese prepubertal children in Lebanon: a primary health concern Ann Nutr Metab 2010 57 2 135 142 21063084
   PubMed Web of Science ®Google Scholar
• Helal O Defoort C Robert S Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress Nutr Metab Cardiovasc Dis 2011 21 9 665 671 20399083
   PubMed Web of Science ®Google Scholar
• Zaki ME El-Bassyouni HT El-Gammal M Kamal S Indicators of the metabolic syndrome in obese adolescents Arch Med Sci 2015 11 1 92 98 25861294
   PubMed Web of Science ®Google Scholar
• Johnson WD Kroon JJM Greenway FL Bouchard C Ryan D Katzmarzyk PT Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001–2006 Arch Pediatr Adolesc Med 2009 163 4 371 377 19349567
   PubMedGoogle Scholar
• Agirbasli M Agaoglu NB Ergonul O Comparison of anthropometric indices in predicting metabolic syndrome components in children Metab Syndr Relat Disord 2011 9 6 453 459 21830913
   PubMed Web of Science ®Google Scholar
• Eshtiaghi R Keihani S Hosseinpanah F Barzin M Azizi F Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran lipid and glucose study Int J Obes 2015 39 3 514 519
   PubMed Web of Science ®Google Scholar
• Agouni A Lagrue-Lak-Hal AH Ducluzeau PH Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome Am J Pathol 2008 173 4 1210 1219 18772329
   PubMed Web of Science ®Google Scholar
• Ueba T Haze T Sugiyama M Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome Thromb Haemost 2008 100 2 280 285 18690348
   PubMed Web of Science ®Google Scholar
• Arteaga RB Chirinos JA Soriano AO Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome Am J Cardiol 2006 98 1 70 74 16784924
   PubMed Web of Science ®Google Scholar
• Hanzu FA Palomo M Kalko SG Translational evidence of endothelial damage in obese individuals: Inflammatory and prothrombotic responses J Thromb Haemost 2011 9 6 1236 1245 21481180
   PubMed Web of Science ®Google Scholar
• Aye M Sazali M Waist circumference and BMI cut-off points to predict risk factors for metabolic syndrome among outpatients in a district hospital Singapore Med J 2012 53 8 545 22941134
   PubMed Web of Science ®Google Scholar
• Bouguerra R Alberti H Smida H Waist circumference cut-off points for identification of abdominal obesity among the Tunisian adult population Diabetes Obes Metab 2007 9 6 859 868 17924868
   PubMed Web of Science ®Google Scholar
• Goichot B Grunebaum L Desprez D Circulating procoagulant microparticles in obesity Diabetes Metab 2006 32 1 82 85 16523191
   PubMed Web of Science ®Google Scholar
• Stepanian A Bourguignat L Hennou S Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss Obesity 2013 21 11 2236 2243 23512861
   PubMed Web of Science ®Google Scholar
• Diamant M Nieuwland R Pablo RF Sturk A Smit JWA Radder JK Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus Circulation 2002 106 19 2442 2447 12417540
   PubMed Web of Science ®Google Scholar
• Chironi GN Boulanger CM Simon A Dignat-George F Freyssinet J-M Tedgui A Endothelial microparticles in diseases Cell Tissue Res 2009 335 1 143 151 18989704
   PubMed Web of Science ®Google Scholar
• Shantsila E Endothelial microparticles: a universal marker of vascular health? J Hum Hypertens 2009 23 5 359 361 19020535
   PubMed Web of Science ®Google Scholar
• Erdeve O Siklar Z Kocaturk PA Dallar Y Kavas GO Antioxidant superoxide dismutase activity in obese children Biol Trace Elem Res 2004 98 3 219 228 15131319
   PubMed Web of Science ®Google Scholar
• Armutcu F Ataymen M Atmaca H Gurel A Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome Clin Chem Lab Med 2008 46 6 785 790 18601599
   PubMed Web of Science ®Google Scholar
• Ozata M Mergen M Oktenli C Increased oxidative stress and hypozincemia in male obesity Clin Biochem 2002 35 8 627 631 12498997
   PubMed Web of Science ®Google Scholar
• Nowotny K Jung T Höhn A Weber D Grune T Advanced glycation end products and oxidative stress in type 2 diabetes mellitus Biomolecules 2015 5 1 194 222 25786107
   PubMed Web of Science ®Google Scholar
• De Oliveira J Hort MA Moreira ELG Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress Neuroscience 2011 197 99 106 21945034
   PubMed Web of Science ®Google Scholar
• Welty FK How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr Cardiol Rep 2013 15 9 400 23881582
   PubMed Web of Science ®Google Scholar
• Demircan N Gurel A Armutcu F Unalacak M Aktunc E Atmaca H The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome Med Sci Monit 2008 14 2 CR97 CR101 18227768
   PubMed Web of Science ®Google Scholar
• Coffey CS Asselbergs FW Hebert PR The association of the metabolic syndrome with PAI-1 and t-PA levels Cardiol Res Pract 2011 2011 4 1 8
   Google Scholar
• Alessi MC Juhan-Vague I PAI-1 and the metabolic syndrome: links, causes, and consequences Arterioscler Thromb Vasc Biol 2006 26 10 2200 2207 16931789
   PubMed Web of Science ®Google Scholar
• Asselbergs FW Williams SM Hebert PR Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels Genomics 2007 89 3 362 369 17207964
   PubMed Web of Science ®Google Scholar
• Kim DK Kim JW Kim S Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1 Arterioscler Thromb Vasc Biol 1997 17 11 3242 3247 9409318
   PubMed Web of Science ®Google Scholar
• Huotari A Lehto SM Niskanen L Increased serum PAI-1 levels in subjects with metabolic syndrome and long-term adverse mental symptoms: a population-based study Cardiovasc Psychiatry Neurol 2010 2010 1 1 7
   Google Scholar